India Proposes Formula for Clinical Trial Death Compensation

Drug Industry Daily
A A
Drug companies conducting clinical trials in India would be required to pay significant compensation for deaths of some subjects during a study, under a proposed formula released last week that lays out the conditions and amounts of payment.

To View This Article:

Login

Subscribe To Drug Industry Daily